๐Ÿซ˜ Physiology ยท Renal

Memory tricks for renal physiology

GFR, tubular reabsorption, acid-base balance, and RAAS.

๐Ÿซ˜ Renal Physiology

Memory Tricks

Proven Mnemonics & Acronyms โ€” fast to learn, hard to forget.

GFR and Filtration Forces
NFP = GHP โˆ’ (COP + CP) โ€” Net Filtration Pressure
Glomerular Hydrostatic Pressure โˆ’ (Colloid Osmotic + Capsule Pressure)
What drives glomerular filtration โ€” the three forces in balance
Net filtration pressure (NFP) determines GFR. Glomerular hydrostatic pressure (GHP, ~55 mmHg) promotes filtration โ€” blood pressure in the glomerulus. Colloid osmotic pressure (COP, ~30 mmHg) opposes filtration โ€” plasma proteins draw water back. Capsule pressure (CP, ~15 mmHg) opposes filtration โ€” fluid already in Bowman's capsule. NFP = 55 โˆ’ (30 + 15) = 10 mmHg. Anything increasing GHP increases GFR. Anything increasing COP or CP decreases GFR. Autoregulation keeps GFR stable from BP 80โ€“180 mmHg.
GHP โ†‘
High BP โ†’ more filtration. Afferent dilation or efferent constriction increases GHP.
COP โ†‘
High plasma proteins โ†’ less filtration. Dehydration concentrates proteins โ†’ GFR drops.
CP โ†‘
Ureteral obstruction โ†’ backs up โ†’ increased capsule pressure โ†’ GFR drops.
Autoregulation
Myogenic reflex + tubuloglomerular feedback keep GFR stable 80โ€“180 mmHg.
PCT Reabsorption
PCT reabsorbs ALL glucose ยท ALL amino acids ยท 65% Na+ ยท 65% water
Proximal convoluted tubule โ€” site of most reabsorption
What the PCT reabsorbs โ€” and the glucose threshold rule
The PCT reabsorbs approximately 65โ€“70% of filtered water, sodium, potassium, and bicarbonate. ALL filtered glucose and amino acids are normally reabsorbed here via secondary active transport (sodium-glucose cotransporter, SGLT2). Glucose threshold: when plasma glucose exceeds ~180 mg/dL, SGLT2 transporters become saturated โ†’ glucose spills into urine (glucosuria). SGLT2 inhibitors (flozins) are diabetes drugs that intentionally block SGLT2 โ†’ glucose lost in urine โ†’ lower blood glucose. PCT is also where many drugs are secreted into the tubule.
Glucose
100% reabsorbed normally. Spills >180 mg/dL. SGLT2 cotransporter.
Amino acids
100% reabsorbed via specific transporters. Fanconi syndrome = failure here.
Na+ (65%)
Na+/K+ ATPase on basolateral side drives reabsorption. Na+ follows down gradient.
HCO3- (90%)
Reabsorbed in PCT as CO2 (carbonic anhydrase). Important for acid-base.
Loop of Henle Countercurrent
Down = water OUT ยท Up = salt OUT ยท Creates medullary gradient
Descending limb: water permeable ยท Ascending limb: impermeable to water, pumps salt
The countercurrent multiplier โ€” how the kidney concentrates urine
The loop of Henle creates a high-osmolarity gradient in the medulla โ€” essential for urine concentration. Descending limb: permeable to water, impermeable to solutes โ†’ water leaves by osmosis โ†’ filtrate becomes more concentrated. Ascending limb (thick): impermeable to water, actively pumps Na+/K+/Cl- OUT โ†’ filtrate becomes dilute, medulla becomes concentrated. The concentrated medullary interstitium then pulls water out of the collecting duct when ADH is present โ†’ concentrated urine produced. Loop diuretics (furosemide) block the Na+/K+/2Cl- pump in the thick ascending limb โ†’ destroy the gradient โ†’ cannot concentrate urine.
Descending limb
Water permeable โ€” osmosis concentrates filtrate. Thin, no active transport.
Thick ascending
Na+/K+/2Cl- pump (NKCC2) โ€” furosemide blocks this. Filtrate dilutes.
Medullary gradient
300 mOsm at cortex โ†’ 1200 mOsm at papilla. Urea contributes 50%.
Furosemide
Blocks NKCC2 โ†’ destroys gradient โ†’ massive water and salt loss โ†’ powerful diuresis.
DCT and Aldosterone
Aldosterone = Na+ IN ยท K+ OUT ยท H+ OUT
Aldosterone acts on DCT and collecting duct principal cells
Aldosterone's action on the distal tubule โ€” and the clinical consequences
Aldosterone is released from the adrenal cortex when angiotensin II rises (low BP) or K+ rises. It binds mineralocorticoid receptors in DCT and collecting duct principal cells โ†’ increases Na+ channels (ENaC) on luminal side โ†’ Na+ reabsorbed โ†’ water follows โ†’ BP rises. Simultaneously increases K+ secretion (K+ exits into tubule โ†’ excreted) and H+ secretion. Conn's syndrome (primary hyperaldosteronism): excess aldosterone โ†’ hypertension + hypokalemia + metabolic alkalosis. Spironolactone is an aldosterone antagonist used as a potassium-sparing diuretic.
Na+ reabsorption
Via ENaC channels โ†’ water follows โ†’ volume expansion โ†’ BP increases.
K+ secretion
K+ excreted in exchange for Na+. Hyperaldosteronism โ†’ hypokalemia.
H+ secretion
Increased H+ loss โ†’ metabolic alkalosis in hyperaldosteronism.
Spironolactone
Aldosterone antagonist โ†’ K+ sparing diuretic. Used in heart failure, Conn's.
RAAS System
Low BP โ†’ Renin โ†’ Angiotensin I โ†’ ACE โ†’ Angiotensin II โ†’ Aldosterone โ†’ BP UP
Renin-Angiotensin-Aldosterone System โ€” the blood pressure cascade
The RAAS cascade โ€” the most important blood pressure regulation system
Low blood pressure or low Na+ โ†’ juxtaglomerular cells release Renin โ†’ Renin cleaves angiotensinogen (liver) โ†’ Angiotensin I โ†’ ACE (lung) converts to Angiotensin II โ†’ Angiotensin II: vasoconstriction (raises BP directly), stimulates aldosterone (Na+/water retention), stimulates ADH, stimulates thirst. ACE inhibitors (lisinopril, enalapril) block conversion โ†’ less Ang II โ†’ less vasoconstriction + less aldosterone โ†’ lower BP. ARBs block Ang II receptors. Both are first-line for hypertension and heart failure.
Renin
From JG cells โ€” low BP, low Na+, sympathetic stimulation trigger release.
ACE
In lung โ€” converts Ang I to Ang II. Also degrades bradykinin (ACE inhibitor cough).
Angiotensin II
Vasoconstriction + aldosterone + ADH + thirst โ†’ all raise BP or volume.
ACE inhibitors
Dry cough (bradykinin accumulates). Contraindicated in pregnancy (teratogenic).
Potassium Regulation
High K+ โ†’ Aldosterone โ†’ K+ OUT ยท Insulin and alkalosis โ†’ K+ IN cells
Factors that shift K+ in and out of cells
Potassium balance โ€” the most clinically dangerous electrolyte
K+ is the most dangerous electrolyte because even small changes cause cardiac arrhythmias. 98% of K+ is intracellular. Factors driving K+ INTO cells: insulin (Na+/K+ ATPase), alkalosis (H+ leaves cells, K+ enters), beta-2 agonists. Factors driving K+ OUT of cells: acidosis (H+ enters cells, K+ leaves), cell lysis, hypertonicity. ECG changes with hyperkalemia: peaked T waves โ†’ wide QRS โ†’ sine wave โ†’ ventricular fibrillation. Treatment of hyperkalemia: calcium gluconate (stabilizes membrane), insulin + glucose (shifts K+ in), sodium bicarbonate (alkalosis shifts K+ in), Kayexalate or dialysis (removes K+).
K+ INTO cells
Insulin, alkalosis, beta-2 agonists, aldosterone. Used to treat hyperkalemia.
K+ OUT of cells
Acidosis, cell lysis (hemolysis, rhabdomyolysis), hypertonicity.
Hyperkalemia ECG
Peaked T โ†’ wide QRS โ†’ sine wave โ†’ VF. Give calcium gluconate first!
Hypokalemia
Flat T waves, U waves. Causes: vomiting, diuretics, hyperaldosteronism.
Sodium Regulation
Na+ controls volume ยท K+ controls electrical ยท Ca2+ controls excitability
The three electrolytes and their primary physiological roles
Why sodium determines fluid volume โ€” and how the body regulates it
Sodium is the primary determinant of extracellular fluid volume โ€” where Na+ goes, water follows. The body regulates Na+ to regulate blood volume, not to regulate osmolarity directly (that's regulated separately by ADH). Hyponatremia (Na+ <135): excess water relative to Na+ โ€” causes cerebral edema โ†’ confusion, seizures. Hypernatremia (Na+ >145): water deficit relative to Na+ โ€” causes cell shrinkage โ†’ thirst, dehydration. ANP (atrial natriuretic peptide) is released when atria stretch โ†’ promotes Na+ excretion โ†’ lowers BP. Opposes RAAS.
Hyponatremia
Na+ <135 โ†’ cells swell โ†’ cerebral edema โ†’ confusion, seizures. Excess water.
Hypernatremia
Na+ >145 โ†’ cells shrink โ†’ thirst, dehydration, altered mental status.
ANP
Released by atria when stretched โ†’ promotes Na+ excretion โ†’ opposes RAAS.
SIADH
Excess ADH โ†’ water retention โ†’ dilutional hyponatremia. Common in lung cancer.
Renal Acid-Base
Kidneys excrete H+ ยท Kidneys regenerate HCO3- ยท Slowest but most powerful buffer
Renal acid-base regulation โ€” slower than lungs but more powerful
How kidneys regulate pH โ€” the long-term acid-base buffer
Lungs respond to acid-base in minutes. Kidneys respond in hours to days but have greater capacity. Kidneys regulate pH by: secreting H+ into the tubule (excretes acid), regenerating HCO3- (returns to blood as base), and excreting ammonium (NH4+) โ€” the main way kidneys excrete acid. In metabolic acidosis: kidneys increase H+ secretion and HCO3- reabsorption, increase ammoniagenesis. Renal tubular acidosis (RTA): kidneys fail to excrete H+ โ†’ hyperchloremic metabolic acidosis with normal anion gap. Type 1 (distal) most common โ€” cannot acidify urine below pH 5.5.
H+ secretion
PCT and collecting duct. Titratable acid and NH4+ are the main H+ carriers.
HCO3- reabsorption
90% in PCT as CO2. Regenerated in intercalated cells of collecting duct.
Ammoniagenesis
Glutamine โ†’ NH3 โ†’ NH4+ excreted. Increases dramatically in acidosis.
RTA Type 1
Cannot acidify urine. Urine pH >5.5 even in acidosis. Kidney stones risk.
Diuretic Classes
LAST โ€” Loop ยท ACE inhibitor ยท Spironolactone ยท Thiazide
Four major diuretic classes โ€” site of action determines potency and electrolyte effects
Diuretics โ€” where each acts and what electrolyte it wastes
Loop diuretics (furosemide): block NKCC2 in thick ascending limb โ€” most powerful. Waste Na+, K+, Cl-, Ca2+, Mg2+. Thiazides (hydrochlorothiazide): block NaCl transporter in DCT. Waste Na+, K+, Mg2+. Retain Ca2+ (used in hypercalciuria/kidney stones). Spironolactone: aldosterone antagonist in DCT/CD. Potassium-sparing. Used in heart failure, Conn's. ACE inhibitors: reduce angiotensin II โ†’ reduce aldosterone โ†’ mild diuresis + K+ retention. Potassium-sparing diuretics also include amiloride (blocks ENaC) and triamterene.
Loop diuretics
Most potent. Furosemide. Hypokalemia, hyponatremia, hypocalcemia, ototoxicity.
Thiazides
Moderate. HCTZ. Hypokalemia, hyperglycemia, hypercalcemia, hyperlipidemia.
Spironolactone
K+ sparing. Gynecomastia (anti-androgen). Used with loops to prevent K+ loss.
Amiloride
Blocks ENaC in collecting duct. K+ sparing. No hormonal side effects.
GFR and Filtration
GFR = 125 mL/min โ€” almost all reabsorbed
๐Ÿ“Œ Glomerular Function
The glomerulus filters 180L/day but the body reabsorbs 99% โ€” only 1.5L excreted
GFR (glomerular filtration rate) = ~125 mL/min = 180 L/day. Of this, ~99% reabsorbed in tubules โ†’ only ~1.5L urine/day. GFR regulated by afferent/efferent arteriole tone (controlled by angiotensin II, prostaglandins, ANS). Creatinine clearance used clinically to estimate GFR.
GGFR = 125 mL/min normal
FFilter 180L/day
RReabsorb 99% โ†’ only 1.5L urine
RAAS System
RAAS Raises All โ€” Renin โ†’ Angiotensin โ†’ Aldosterone โ†’ Sodium
๐Ÿ“Œ Fluid Regulation
The renin-angiotensin-aldosterone system raises BP by retaining sodium and water
Low BP/Na โ†’ kidney JGA releases renin โ†’ cleaves angiotensinogen to Ang I โ†’ ACE converts to Ang II (lungs) โ†’ Ang II: vasoconstriction + stimulates aldosterone from adrenal cortex โ†’ aldosterone: Na+ reabsorption in collecting duct โ†’ โ†‘ water retention โ†’ โ†‘ BP.
RRenin โ€” from JGA of kidney
AAngiotensin II โ€” vasoconstriction
AAldosterone โ€” Na+ retention
SSodium + water โ†’ โ†‘ BP
Acid-Base Balance
ROME โ€” Respiratory Opposite ยท Metabolic Equal
๐Ÿ“Œ pH Regulation
Use ROME to determine if compensation is respiratory or metabolic on ABG questions
Respiratory: pH and CO2 move in OPPOSITE directions (โ†‘CO2 โ†’ โ†“pH = respiratory acidosis). Metabolic: pH and HCO3 move in EQUAL/same direction (โ†“HCO3 โ†’ โ†“pH = metabolic acidosis). Kidneys compensate for respiratory disorders; lungs compensate for metabolic disorders.
RRespiratory โ€” pH and CO2 Opposite
OOpposite directions = respiratory
MMetabolic โ€” pH and HCO3 Equal
EEqual direction = metabolic
ADH and Osmolality
ADH = Add water back ยท No ADH = Dilute urine out
๐Ÿ“Œ Water Balance
ADH (vasopressin) concentrates urine by inserting aquaporins in collecting duct
High plasma osmolality โ†’ hypothalamus releases ADH โ†’ aquaporin-2 channels inserted into collecting duct โ†’ water reabsorption โ†’ concentrated urine. Low osmolality or high volume โ†’ ADH suppressed โ†’ dilute urine. Diabetes insipidus: ADH absent โ†’ massive dilute urine output.
AADH = aquaporins inserted
DDilute plasma โ†’ suppress ADH
HHigh osmolality โ†’ release ADH
🎓 Common Exam Questions
Q: What are the four main functions of the nephron tubule segments?
A: Proximal Convoluted Tubule (PCT): reabsorbs ~67% of filtered Na+, water, glucose (all), amino acids (all), HCO3, phosphate. Site of secretion for many drugs. Loop of Henle: thin descending: water permeable, salt impermeable โ†’ concentrates filtrate. Thick ascending: salt reabsorbed (Na+/K+/2Clโˆ’ cotransporter โ€” target of loop diuretics), water impermeable โ†’ dilutes filtrate. Distal Convoluted Tubule (DCT): Na+/Clโˆ’ reabsorption (thiazide target); Ca2+ reabsorption (PTH-regulated). Collecting Duct: water reabsorption (ADH-regulated via aquaporin-2); Na+ reabsorption + K+/H+ secretion (aldosterone-regulated).
Q: Explain the four primary acid-base disorders and their compensation.
A: Respiratory acidosis: โ†‘CO2 (hypoventilation) โ†’ โ†“pH. Renal compensation: retain HCO3. Respiratory alkalosis: โ†“CO2 (hyperventilation) โ†’ โ†‘pH. Renal compensation: excrete HCO3. Metabolic acidosis: โ†“HCO3 โ†’ โ†“pH. Causes: MUDPILES (Methanol, Uremia, DKA, Propylene glycol, Isoniazid, Lactic acidosis, Ethylene glycol, Salicylates). Respiratory compensation: Kussmaul breathing (โ†“CO2). Metabolic alkalosis: โ†‘HCO3 โ†’ โ†‘pH. Causes: vomiting (lose HCl), diuretics (lose H+), excess antacids. Respiratory compensation: hypoventilation (โ†‘CO2). Use ROME to identify: Respiratory = Opposite pH-CO2; Metabolic = Equal pH-HCO3.
Q: How does the RAAS system regulate blood pressure and how do ACE inhibitors work?
A: Low BP or low Na+ โ†’ juxtaglomerular apparatus (JGA) releases renin โ†’ cleaves angiotensinogen (liver) โ†’ angiotensin I โ†’ ACE (lung endothelium) converts โ†’ angiotensin II. Ang II effects: (1) potent vasoconstriction โ†’ โ†‘ BP, (2) stimulates adrenal cortex โ†’ aldosterone โ†’ Na+ retention in collecting duct โ†’ โ†‘ water โ†’ โ†‘ volume โ†’ โ†‘ BP, (3) stimulates ADH release, (4) promotes cardiac/vascular remodeling. ACE inhibitors block Ang II formation โ†’ vasodilation + less aldosterone + less ADH. Side effect: dry cough (โ†‘ bradykinin). ARBs block Ang II receptor โ€” same effect, no cough.
Q: What causes hyperkalemia and hypokalemia and why are they dangerous?
A: Hypokalemia (K+ < 3.5 mEq/L): causes: vomiting/diarrhea (GI loss), loop/thiazide diuretics, hyperaldosteronism, insulin (shifts K+ into cells), alkalosis (H+ leaves cells in exchange for K+). Effects: muscle weakness, cramps, constipation, U waves on ECG, arrhythmias, polyuria (nephrogenic DI). Hyperkalemia (K+ > 5.5 mEq/L): causes: renal failure (can't excrete), hypoaldosteronism, ACE inhibitors/K+-sparing diuretics, acidosis (H+ enters cells โ†’ K+ exits), cell lysis (rhabdomyolysis, hemolysis). Effects: muscle weakness, peaked T waves โ†’ wide QRS โ†’ sine wave โ†’ V-fib โ†’ death. Treatment: calcium gluconate (stabilizes membrane), insulin+glucose (shifts K+ in), kayexalate/dialysis (removes K+).
Q: What is the difference between prerenal, intrinsic renal, and postrenal acute kidney injury?
A: Prerenal AKI: reduced perfusion to kidneys (hypovolemia, heart failure, sepsis, NSAIDs). Kidneys structurally intact โ€” respond appropriately: โ†‘ BUN/Cr ratio (>20:1), concentrated urine (Osm >500), low urine Na+ (<20 mEq/L), high FENa (<1%). Treat the underlying cause โ†’ kidneys recover. Intrinsic renal AKI: direct kidney damage. Most common: ATN (acute tubular necrosis) from ischemia or nephrotoxins (aminoglycosides, contrast, myoglobin). Urine Na+ high (>40), FENa >2%, muddy brown casts. Postrenal AKI: obstruction (BPH, kidney stones, tumors). Both kidneys must be blocked (or single functioning kidney). Relieve obstruction โ†’ recovery.